the presence and size of JBA predicts future ipsilateral ischemic stroke.
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The Hemodynamic Impact of Balloon Angioplasty in
Objectives:
Recently an association has been made between Multiple Sclerosis (MS) and Chronic Cerebrospinal Venous Insufficiency (CCSVI) characterized by stenosis and reflux of the principal extracranial venous drainage including the Internal Jugular veins (IJV) and the Azygous veins (AZV). This is the first angiographic study to quantitatively analyze the impact of percutaneous balloon angioplasty (PTA) on flow dynamics across these lesions.
Methods: 50 IJV form MS patients with CCSVI and 12 IJV from healthy volunteers underwent detailed angiographic evaluation. Technical components of all venograms were standardized. Quantitative analysis included the contrast time of flight (TOF) from the mid IJV to the superior vena cava, and the primary venous emptying time (PVET), quantified as Ͼ50% of venous emptying, from the IJV. The TOF and PVET were recorded in patients with CCSVI prior and subsequent to balloon angioplasty, as well in normal healthy subjects. All data was prospectively collected, and statistical analysis was performed using two-tailed Student's test.
Results: Of the 50 CCSVI-MS patients with IJV stenosis Ͼ70% and reflux underwent balloon angioplasty, technical success defined as Ͻ20% residual IJV stenosis was achieved in 78% (44/50). The Table describes the pre and post angioplasty TOF and PVET in patients with CCSVI, as well as in healthy non-MS patients without any treatment. CCSVI patients were noted to have a significant improvement in both the TOF and PVET following balloon angioplasty that paralleled healthy non-MS subjects.
Conclusions: Results of this prospective pilot study suggest an association between MS and CCSVI, which results in abnormally elevated TOF and PEVT through the IJV. Furthermore, balloon angioplasty these lesions improves the hemodynamic parameters that are comparable to healthy non-MS patients. Objectives: Relevance of training has been recognized as a key factor for safety of Carotid stenting (CAS).
The objective of this study was to evaluate whether the center learning curve could shortcut the training of new trainees with CAS.
Methods: Consecutive CAS procedures performed from 2001 to 2010 were reviewed. The learning curve phase (years 2001-2003) was performed by the "leader team" ("historical team") including vascular surgeons and interventional radiologists who first approached CAS. Learning curve included acquisition of handle skill with CAS procedural steps and best selection of patients and materials. Periprocedural complications after the learning curve in the "leader team phase" (the historical team continued to perform all procedures in [2004] [2005] [2006] and in the "expanded team phase" (5 new trainees joined the historical team in 2006-2010) were measured.
Results: A total of 1540 CAS were reviewed. The first 195 represented the learning curve. Of the remaining 1345 CAS, 431 were performed in the "leader phase" and 914 in the "expanded team phase". Individual operator volume for the new trainees ranged from 20 to 188 CAS. Periprocedural complications were similarly low in the two phases: strokes (2.8% vs 2.2%; P ϭ .56) major strokes (0.9% vs 0.8%, P ϭ .75), death (0.2% vs 0%; P ϭ .3) for the leader and expanded team phase respectively. Mean procedure time was longer (43 min vs 38 min) in the expanded team phase, while rates of immediate conversions (1.0% vs 3.5%, P ϭ .03) and mean contrast use (69mL vs 92mL; P Ͻ.0001) decreased.
Conclusions: The primary factor driving stroke reduction with CAS is the center experience. CAS complication rate is not based on individual rules but most likely on the center/team practice also defining how to select patients and materials best suited for the procedure. Appropriate learning curve of the center can reliably shortcut the training of new trainees preserving CAS safety and efficacy.
